Hong Kong Journal of Nephrology
Volume 9, Issue 1 , Pages 23-30, April 2007

Warfarin Versus Aspirin in Preventing Tunneled Hemodialysis Catheter Thrombosis: A Prospective Randomized Study

  • Ibrahiem Saeed Abdul-Rahman

      Affiliations

    • Corresponding Author InformationAddress correspondence and reprint request to: Dr. Ibrahiem Saeed, Nephrology Division, Department of Internal Medicine, King Fahd Hospital of the University, P.O. Box 40032, Al Khobar 31952, Saudi Arabia. Fax: (+966) 3-8966741
    • ,
  • Abdulla K. Al-Howaish

Nephrology Division, Department of Internal Medicine, King Fahd Hospital of the University, King Faisal University, Al Khobar, Saudi Arabia

Article Outline

Background

Vascular access complications are the greatest cause of morbidity and hospitalization in hemodialysis patients. The most frequent complication of central catheters used for hemodialysis is dysfunction due to thrombosis. Tunneled hemodialysis catheter thrombosis represents a major medical and economic burden. Although systemic anticoagulation is commonly prescribed to prevent thrombosis and malfunction of the vascular access during hemodialysis, there are only limited data regarding the effect of systemic anticoagulation or antiplatelet activation in between dialysis sessions.

Methods

This randomized prospective study aimed to evaluate whether anticoagulation with adjusted-dose warfarin or low dose aspirin is associated with a long-term improvement of tunneled hemodialysis catheter thrombosis outcome. Among the 58 patients included in the study, 20 were placed on daily warfarin and 19 on aspirin, while 19 were used as control.

Results

Among patients receiving warfarin, 18 (90%) achieved adequate anticoagulation (i.e. INR value within target range), and four (20%) had at least one episode of catheter malfunction due to catheter thrombosis. Four (21.1%) patients on aspirin had one or more episodes of catheter malfunction because of central venous catheter thrombosis (p > 0.05), while nine (47.4%) out of the 19 control patients had tunneled catheter thrombosis with catheter malfunction (p < 0.01). Malfunction-free catheter survival at 12 months was 75% in the warfarin group, 68.4% in the aspirin group, and 36.8% in the control group. There was no statistically significant difference between the warfarin and aspirin groups, while the difference between the warfarin or aspirin group and the control group was statistically significant (p < 0.01).

Conclusion

These results suggest that both warfarin and aspirin are effective in preventing tunneled hemodialysis catheter thrombosis and increasing long-term malfunction-free catheter survival.

Key words:  aspirin , hemodialysis , thrombosis , tunneled central venous catheter , warfarin

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Windus DW . Permanent vascular access: a nephrologist's view . Am J Kidney Dis . 1993;21:457–471
  2. Hakim R , Himmelfarb J . Hemodialysis access failure: a call to action . Kidney Int . 1998;54:1029–1040
  3. Smits JH , van der Linden J , Blankestijn PJ , Rabelink TJ . Coagulation and haemodialysis access thrombosis . Nephrol Dial Transplant . 2000;15:1755–1760
  4. Feldman HI , Kobrin S , Wasserstein A . Hemodialysis vascular access morbidity . J Am Soc Nephrol . 1996;7:523–535
  5. Feldman HI , Held PJ , Hutchinson JT , Stoiber E , Hartigan MF , Berlin JA . Hemodialysis vascular access morbidity in the United States . Kidney Int . 1993;43:1091–1096
  6. Bern MM , Lokich JJ , Wallach SR , Bothe A , Benotti PN , Arkin CF , et al.   Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial . Ann Intern Med . 1990;112:423–428
  7. Boraks P , Seale J , Price J , Bass G , Ethell M , Keeling D , et al.   Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies . Br J Haematol . 1998;101:483–486
  8. Obialo CI , Conner AC , Lebon LF . Maintaining patency of tunneled hemodialysis catheters—efficacy of aspirin compared to warfarin . Scand J Urol Nephrol . 2003;37:172–176
  9. Haire WD , Lieberman RP , Lund GB , Edney JA , Kessinger A , Armitage JO . Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters . Bone Marrow Transplant . 1991;7:57–59
  10. NKF-DOQI Clinical Practice Guidelines for Vascular Access. Guideline 23: treatment of tunneled cuffed catheter dysfunction . Am J Kidney Dis . 1997;30(Suppl 3):S175–S176
  11. Suhocki PV , Conlon PJ , Knelson MH , Harland R , Schwab SJ . Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction . Am J Kidney Dis . 1996;28:379–386
  12. Lund GB, Trerotola SO, Scheel PF, Savader SJ, Mitchell SE, Venbrux AC, et al. Outcome of tunneled hemodialysis catheters placed by radiologists . Radiology . 1996;198:467–472
  13. Rysz J , Majewska E , Stolarek RA , Banach M , Cialkowska-Rysz A , Baj Z . Increased levels of soluble TNF-alpha receptors and cellular adhesions molecules in patients undergoing bioincompatible hemodialysis . Am J Nephrol . 2006;26:437–444
  14. Agraharkar M , Isaacson S , Mendelssohn D , Muralidharan J , Mustata S , Zevallos G , et al.   Percutaneously inserted silastic jugular hemodialysis catheters seldom cause jugular vein thrombosis . ASAIO J . 1995;41:169–172
  15. Karnik R , Valentin A , Winkler WB , Donath P , Slany J . Duplex sonographic detection of internal jugular venous thrombosis after removal of central venous catheters . Clin Cardiol . 1993;16:26–29
  16. Cox K , Vesely TM , Windus DW . The utility of brushing dysfunctional hemodialysis catheters . JVIR . 2000;11:979–983
  17. Uldall R , Besley ME , Thomas A . Maintaining the patency OF double-lumen silastic jugular catheters for hemodialysis . Int J Artif Organs . 1993;16:37–40
  18. Zellweger M , Bouchard J , Raymond-Carrier S , Laforest-Renald A , Querin S , Madore F . Systemic anticoagulation and prevention of hemodialysis catheter malfunction . ASAIO J . 2005;51:360–365
  19. Merport M , Murphy TP , Egglin TK , Dubel GJ . Fibrin sheath stripping versus catheter exchange for the treatment of failed tunneled hemodialysis catheters: randomized clinical trial . J Vasc Interv Radiol . 2000;11:1115–1120
  20. O'Farrel LO , Griffith JW , Lang CM . Histologic development of the sheath that forms around long term implanted central venous catheters . J Parenter Enteral Nutr . 1996;20:156–158
  21. Haskal ZJ , Leen VH , Thomas-Hawkins C , Shlansky-Goldberg RD , Baum RA , Soulen MC . Transvenous removal of fibrin sheaths from tunneled hemodialysis catheters . J Vasc Interv Radiol . 1996;7:513–517
  22. Di Minno G , Martinez J , McKean ML , De La Rosa J , Burke JF , Murphy S . Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis . Am J Med . 1985;79:552–559
  23. Eknoyan G , Brown CHD . Biochemical abnormalities of platelets in renal failure. Evidence of decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase . Am J Nephrol . 1981;1:17–23
  24. Remuzzi G , Benigni A , Dodesini P , Schieppati A , Livio M , De Gaetano G , et al.   Reduced platelet thromboxane formation in uremia. Evidence for functional cyclooxygenase defect . J Clin Invest . 1983;71:762–768
  25. Escolar G , Cases A , Bastida E , Garrido M , Lopez J , Revert L , et al.   Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa . Blood . 1990;76:1336–1340
  26. Gawaz MP , Dobos G , Spath M , Schollmeyer P , Gurland HJ , Mujais SK . Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease . J Am Soc Nephrol . 1994;5:36–46
  27. Lindahl TL , Lundahl J , Netre C . Studies of the platelet fibrinogen receptor in Glanzmann patients and uremic patients . Thromb Res . 1992;67:457–466
  28. Walkowiak B , Pawlowska Z , Michalak E , Cierniewski CS . Expression of fibrinogen receptors on platelets of uremic patients is correlated with the content of GPIIb and plasma level of creatinine . Thromb Haemost . 1994;71:164–168
  29. Sreedhara R , Itagaki I , Hakim RM . Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors . Am J Kidney Dis . 1996;27:355–364
  30. Noris M , Remuzzi G . Uremic bleeding: closing the circle after 30 years of controversies? . Blood . 1999;94:2569–2574
  31. Simon DI , Stamler JS , Loh E , Loscalzo J , Francis SA , Creager MA . Effect of nitric oxide synthase inhibition on bleeding time in humans . J Cardiovasc Pharmacol . 1995;26:339–342
  32. Noris M , Remuzzi G . Physiology and pathophysiology of nitric oxide in chronic renal disease . Proc Assoc Am Physicians . 1999;111:602–610
  33. Vaziri ND . Effect of chronic renal failure on nitric oxide metabolism . Am J Kidney Dis . 2001;38:S74–S79
  34. Deguchi N , Ohigashi T , Tazaki H , Handa M , Ikeda Y . Haemodialysis and platelet activation . Nephrol Dial Transplant . 1991;6(Suppl 2):40–42
  35. Reverter JC , Escolar G , Sanz C , Cases A , Villamor N , Nieuwenhuis HK , et al.   Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flow cytometric and ultrastructural techniques . J Lab Clin Med . 1994;124:79–85
  36. Viener A , Aviram M , Better OS , Brook JG . Enhanced in vitro platelet aggregation in hemodialysis patients . Nephron . 1986;43:139–143
  37. Shrivastava D , Lundin AP , Dosunmu B , Rao TK , Beyer MM , Friedman EA . Salvage of clotted jugular vein hemodialysis catheters . Nephron . 1994;68:77–79
  38. Garofalo RS , Zaleski GX , Lorenz JM , Funaki B , Rosenblum JD , Leef JA . Exchange of poorly functioning tunneled permanent hemodialysis catheters . AJR AM J Roentgenol . 1999;173:155–158
  39. Haire WD , Lieberman RP . Thrombosed central venous catheters: restoring function with 6-hour urokinase infusion after failure of bolus urokinase . J Parenter Enteral Nutr . 1989;13:92–98
  40. Haire WD , Atkinson JB , Stephens LC , Kotulak GD . Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial . Thromb Haemost . 1994;72:543–547
  41. Savader SJ , Haikal LC , Ehrman KO , Porter DJ , Oteham AC . Hemodialysis catheter-associated fibrin sheath: treatment with low dose rt-PA infusion . J Vasc Interv Radiol . 2000;11:1131–1136
  42. Brady PS , Spence LD , Levitin A , Mickolich CT , Dolmatch BL . Efficacy of percutaneous fibrin sheath stripping in restoring patency of tunneled hemodialysis catheters . AJR Am J Roentgenol . 1999;173:1023–1027
  43. Schon D , Whittman D . Managing the complications of long-term tunneled dialysis catheters . Semin Dial . 2003;16:314–322
  44. Beathard GA . Dysfunction of new catheters by old fibrin sheath . Semin Dial . 2004;17:243–244
  45. Mokrzycki MH , Jean-Jerome K , Rush H , Zdunek MP , Rosenberg SO . A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters . Kidney Int . 2001;59:1935–1942
  46. Pierratos A , Ouwendyk M , Francoeur R , Vas S , Raj DS , Ecclestone AM , et al.   Nocturnal hemodialysis: three-year experience . J Am Soc Nephrol . 1998;9:859–868
  47. Twardowski ZJ . Stepwise anticoagulation with warfarin for prevention of intravenous catheter thrombosis . Hemodial Int . 2000;4:37–41
  48. Sagripanti A , Cupisti A , Baicchi U , Ferdeghini M , Morelli E , Barsotti G . Plasma parameters of the prothrombotic state in chronic uremia . Nephron . 1993;63:273–278
  49. Sagedal S , Hartmann A , Sundstrom K , Bjornsen S , Brosstad F . Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets . Nephrol Dial Transplant . 2001;16:987–993
  50. Wanner C , Zimmermann J , Quaschning T , Galle J . Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients . Kidney Int . 1997;62:S53–S55
  51. De Lima JJ, Sesso R, Abensur H, Lopes HF, Giorgi MC, Krieger EM, et al. Predictors of mortality in long-term haemodialysis patients with a low prevalence of comorbid conditions . Nephrol Dial Transplant . 1995;10:1708–1713
  52. Rugman FP , Jenkins JA , Duguid JK , Maggs PB , Hay CR . Prothrombin fragment F1 + 2: correlation with cardiovascular risk factors . Blood Coagul Fibrinolysis . 1994;5:335–340

PII: S1561-5413(07)60005-2

doi:10.1016/S1561-5413(07)60005-2

Hong Kong Journal of Nephrology
Volume 9, Issue 1 , Pages 23-30, April 2007

Article Tools